CLINICAL_TRIALS
trial_result
· 2014-03-19
Clinical Trial Update: Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma [Phase 2]
Summary
Phase 2 trial of letrozole in women with advanced ER/PR-positive uterine leiomyosarcoma has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Leiomyosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2014-03-19